Coronavirus | Sputnik V to be available in Indian markets by next week
3 years, 7 months ago

Coronavirus | Sputnik V to be available in Indian markets by next week

The Hindu  

Sputnik V vaccine against Covid-19 developed by Russia's Gamaleya National Center will be available in India markets from early next week said NITI Aayog member V.K. “Central Government in its new liberalized strategy, has made specific provisions that vaccines for COVID-19, which have been developed and are being manufactured in foreign countries and which have been granted emergency use authorization by National Regulators of United States, European Medicine Agency, United kingdom, Japan or which are listed in WHO, will be granted emergency use approval in India,” it noted. Speaking at the conference Dr. Paul explained that the new “Liberalized Pricing and Accelerated National Covid-19 Vaccination Strategy” aims at liberalized vaccine pricing and scaling up of vaccine coverage to incentivize vaccine manufacturers to rapidly augment their production and to attract new vaccine manufacturers. It added that the new Liberalized Pricing and Accelerated National Covid-19 Vaccination Strategy also incentivizes in terms of prices to attract private manufacturers including offshore vaccine manufacturers to enter the country.

Technology Russia Indian Transfer Production Vaccines Paul Central Government Manufacturers Available Vaccine Bharat Biotech Sputnik V India Sputnik Technology Transfer Agreements  ministry  markets  available  manufacturers  v  vaccines  transfer  indian  covid19  paul  technology  coronavirus  india  sputnik  production  week  vaccine

History of this topic

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR
6 months ago

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR

The Hindu  

India’s first indigenously developed coronavirus vaccine, Covaxin, was a joint collaboration between the Indian Council of Medical Research and the Hyderabad-based Bharat Biotech International Limited with intellectual property rights jointly shared between the two organisations. The Minister’s statement said the ICMR would provide a “well characterised” virus strain for vaccine development, the BBIL would develop the final vaccine formulation and, …

Bharat Biotech, Bilthoven Biologicals Announce Collaboration To Produce and Supply Oral Polio Vaccines
8 months, 3 weeks ago

Bharat Biotech, Bilthoven Biologicals Announce Collaboration To Produce and Supply Oral Polio Vaccines

Deccan Chronicle  

Hyderabad: Vaccine maker Bharat Biotech and Bilthoven Biologicals BV, a wholly owned subsidiary of Serum Institute of India Private Limited, based in the Netherlands, announced a collaboration to strengthen the production and supply security of oral polio vaccines. A requisite agreement has been signed wherein Bharat Biotech will procure drug substances for the production of oral polio vaccines to be …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

Tackling the new variants
2 years, 4 months ago

Tackling the new variants

Hindustan Times  

The first redesigned coronavirus vaccine was approved for use this week when authorities in the United Kingdom cleared a Moderna dose that the company adapted to create immunity against the Omicron variant. The vaccine is a 50-50 formulation of Moderna’s 2020 product, designed on the Sars-CoV-2 variant that first spread around the world, and of a new dose developed using …

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine
2 years, 5 months ago

Exclusive: Coming soon, second generation, variant specific anti-Covid vaccine

India Today  

The Centre has invested in developing a strain specific vaccine that would help in countering the changing nature of coronavirus. An official who facilitated developing this ecosystem for second generation vaccines told India Today that research and development work is underway to develop strain-specific vaccines in India. A bivalent vaccine will target the specific spike mutations seen in the Omicron …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

Too little, too late: The Hindu Editorial on COVID-19 vaccines and patent rights
2 years, 9 months ago

Too little, too late: The Hindu Editorial on COVID-19 vaccines and patent rights

The Hindu  

In 2020, a key question that the pandemic posed was whether nations would act in solidarity and prioritise equity for the larger good over narrow self-interest. It was amid this turmoil that India and South Africa had proposed at the WTO that all patent rights for COVID-19 vaccines, drugs and diagnostics be temporarily suspended to ensure smooth manufacture and distribution. …

Patent rights on COVID-19 vaccines may be waived for five years
2 years, 9 months ago

Patent rights on COVID-19 vaccines may be waived for five years

The Hindu  

Intellectual property rights held by international pharmaceutical companies on COVID-19 vaccines may be relaxed for up to five years, according to a proposal by the European Union in the backdrop of a festering two-year-old dispute at the World Trade Organisation involving India, U.S., South Africa and the EU. This reprieve will, however, not apply to COVID-19 drugs and diagnostic devices, …

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer
2 years, 9 months ago

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer

News 18  

The sanctions imposed by the United States on the Russian Direct Investment Fund, which markets Sputnik V internationally has raised concerns over the manufacturing of the Covid-19 vaccine in India, the second largest producer of the jab after Russia. RDIF is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and …

Single-dose Sputnik Light Covid vaccine gets approval for emergency use in India
2 years, 10 months ago

Single-dose Sputnik Light Covid vaccine gets approval for emergency use in India

India Today  

The Drugs Controller General of India has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine on Sunday. DCGI has granted emergency use permission to Single-dose Sputnik Light COVID-19 vaccine in India. — Dr Mansukh Mandaviya February 6, 2022 An expert panel of India's central drug authority on Friday recommended granting restricted emergency use authorisation to the single-dose Covid-19 …

Trying to Bring Sputnik M Vaccine for Adolescents to India: Dr Reddy's
2 years, 10 months ago

Trying to Bring Sputnik M Vaccine for Adolescents to India: Dr Reddy's

News 18  

Dr Reddy’s Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia’s Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India. Addressing a press conference after announcing the company’s Q3 results, a senior executive of the drug maker said Phase 3 clinical trial data of Russia’s single dose COVID-19 vaccine Sputnik …

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48
3 years ago

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48

News 18  

As the World Health Organization grants an emergency approval to Serum Institute of India’s Covovax, a top Indian government scientist has recommended that it be used as a booster shot to counter the threat posed by the emerging omicron variant of coronavirus, India Today reported. French Prime Minister Jean Castex says the Omicron variant will be the dominant strain of …

India needs vaccines that can quickly adapt to corona variants: VK Paul
3 years ago

India needs vaccines that can quickly adapt to corona variants: VK Paul

India Today  

Amid the Omicron threat, Niti Aayog member Dr VK Paul said on Tuesday that there is a potential scenario that our Covid-19 vaccines may become ineffective and India should have vaccine platforms that are 'adaptable quickly' with changing nature of the coronavirus variants. Addressing an event organised by industry body CII, the Covid Task Force chief called for modifying the …

Explained | Why are U.S. COVID-19 vaccines still out of reach in India?
3 years, 1 month ago

Explained | Why are U.S. COVID-19 vaccines still out of reach in India?

The Hindu  

The story so far : More than six months after the government announced it would fast-track clearances for foreign COVID-19 vaccines to India, the indemnity clause is still holding up the import of all American vaccines to India, including those manufactured by Pfizer, Johnson & Johnson and Moderna. If it all any indemnity is to be granted to any company …

Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 1 month ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

India Finds No New Covid-19 Variant of Concern in Last Half Year, Says NTAGI Chairman
3 years, 2 months ago

India Finds No New Covid-19 Variant of Concern in Last Half Year, Says NTAGI Chairman

News 18  

Member of the national task force and chairman of Covid working group of National Technical Advisory Group on Immunisation, Dr NK Arora, on Monday said that no new coronavirus variant of concern emerged in the last six months. Meanwhile, more than 102 crore COVID-19 vaccine doses have been provided to states and union territories so far, the Union Health Ministry …

India Allows Export of Russia’s Sputnik Light Covid Jab Produced by Hyderabad’s Hetero Biopharma
3 years, 2 months ago

India Allows Export of Russia’s Sputnik Light Covid Jab Produced by Hyderabad’s Hetero Biopharma

News 18  

The government has permitted the export of Russia’s single-dose COVID-19 vaccine Sputnik Light domestically produced here, Sputnik V confirmed on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April. The Russian ambassador had urged the …

Govt allows export of Russia’s Sputnik Light Covid-19 vaccine made in India
3 years, 2 months ago

Govt allows export of Russia’s Sputnik Light Covid-19 vaccine made in India

Live Mint  

New Delhi: The government has permitted the export of Russia's single-dose COVID-19 vaccine Sputnik Light domestically produced here as the jab has not yet been approved for emergency use in India, sources said on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India's anti-COVID inoculation programme after getting emergency …

WHO still reviewing Sputnik V vaccine, as Russia presses bid
3 years, 2 months ago

WHO still reviewing Sputnik V vaccine, as Russia presses bid

Associated Press  

GENEVA — The World Health Organization is still reviewing data about Russia’s Sputnik V vaccine as part of hopes that it can be approved by the U.N. health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent. The clarification comes after Russian Health Minister Mikhail Murashko in recent days said that administrative issues were among …

Sputnik Light, J&J take another step towards joining India's COVID vaccine arsenal
3 years, 3 months ago

Sputnik Light, J&J take another step towards joining India's COVID vaccine arsenal

Firstpost  

While Sputnik Light has received DCGI’s approval for phase-3 bridging trials, around 35 lakh doses of J&J’s vaccine have been dispatched for final round of quality and safety checks in HP In an affidavit dated 26 June, the Centre had told the Supreme Court that a total of 135 crore doses of COVID-19 vaccines will be made available to the …

Dr Reddy’s Labs gets approval for phase 3 trials of Sputnik Light in India
3 years, 3 months ago

Dr Reddy’s Labs gets approval for phase 3 trials of Sputnik Light in India

Hindustan Times  

India’s drugs regulator has granted permission to Dr Reddy’s Laboratories to conduct phase 3 clinical trials for Sputnik Light, the single dose and first component of the Russian made Sputnik V vaccine against Coronavirus disease. The subject expert committee of the Central Drugs Standard Control Organisation, in its 172nd meeting last month, recommended the drugs controller to grant approval to …

Use Premises Of HLL Biotech Limited In Tamil Nadu To Produce COVID Vaccines: Plea In Supreme Court
3 years, 3 months ago

Use Premises Of HLL Biotech Limited In Tamil Nadu To Produce COVID Vaccines: Plea In Supreme Court

Live Law  

The Supreme Court will hear tomorrow a plea seeking directions to the Union Government to hand over the premises of HLL Biotech Limited in Chengalpet to the government of Tamil Nadu on lease to produce CoVID 19 vaccines. Filed by S Jimraj Milton through Advocate on Record T.S Sabarish, the plea states that India despite being home to the largest …

India's First mRNA-Based Covid Vaccine Gets DCGI Approval For Phase 2-3 Trials
3 years, 3 months ago

India's First mRNA-Based Covid Vaccine Gets DCGI Approval For Phase 2-3 Trials

ABP News  

New Delhi: India's first mRNA-based Covid-19 vaccine on Tuesday got the Drugs Controller General of India nod to move into Phase 2 and 3 trials. According to reports, the Centre informed that the vaccine developed by Gennova Biopharmaceuticals Ltd. was found to be safe, and was given go-ahead for Phase II/III trials. "After establishing the safety of our mRNA-based COVID-19 …

Sputnik V hits production roadblock for second dose of Covid vaccine | Exclusive
3 years, 4 months ago

Sputnik V hits production roadblock for second dose of Covid vaccine | Exclusive

India Today  

Russia’s Sputnik V has reportedly hit a roadblock in the development of the second dose of its Covid-19 vaccine in India. "Production in India is expected to come fully onstream in September and RDIF expects India to become a major production hub for the Sputnik V vaccine with such companies as Serum Institute of India, the world’s biggest vaccine producer, …

India procured over 100 crore vaccines between Jan and July 16
3 years, 4 months ago

India procured over 100 crore vaccines between Jan and July 16

India Today  

The government has procured a total of 100.6 crore doses from January, 2021 till July 16, 2021, said Union MoS for Ministry of Health and Family Welfare, Dr. Bharati Pravin Pawar, in Rajya Sabha. Dr. Bharati Pravin Pawar was replying to a question by Congress MP Kapil Sibal on the timeline of orders placed for Covid-19 vaccines by the Centre …

Kerala plans to sign agreement with RDIF to fill Sputnik V vaccine vials
3 years, 5 months ago

Kerala plans to sign agreement with RDIF to fill Sputnik V vaccine vials

Hindustan Times  

Kerala may soon enter a deal with the Russian Direct Investment Fund, the country’s sovereign wealth fund, to set up a unit for filling Sputnik V Covid-19 vaccine vials, news agency ANI reported. The RDIF has entered into a partnership with Dr Reddy’s Labs to market the first 250 million doses of Sputnik V in India. Kerala industries principal secretary …

Government funding work on four new COVID-19 vaccine candidates
3 years, 5 months ago

Government funding work on four new COVID-19 vaccine candidates

The Hindu  

The Centre is funding the development of four vaccines, which are currently in various stages of human trials. The government has also funded clinical trial sites, animal challenge facilities and immunoassay laboratories, all of which were collectively allotted a budget of ₹900 crore for 12 months, the Minister said. The four vaccines, being funded under Mission Covid Suraksha, were the …

Serum Institute of India to start manufacturing Sputnik V in September, says RDIF
3 years, 5 months ago

Serum Institute of India to start manufacturing Sputnik V in September, says RDIF

Firstpost  

As per the agreement between the Russian Direct Investment Fund and Serum Institute, the parties intend to produce over 300 million doses of the vaccine in India per year New Delhi: Serum Institute of India will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund said on Tuesday. As per the agreement between RDIF …

Serum Institute to produce Russia’s Sputnik V vaccine
3 years, 5 months ago

Serum Institute to produce Russia’s Sputnik V vaccine

The Hindu  

Serum Institute of India will be producing atleast 300 million doses of Sputnik V a year, with the first batch of the Russian vaccine against Covid-19 from its facility likely to be rolled out in September. These details emerged with the Russia’s sovereign wealth fund RDIF on Tuesday announcing a collaboration with the vaccine maker to manufacture Sputnik V for …

SII to produce 300 million doses of Sputnik V jabs annually
3 years, 5 months ago

SII to produce 300 million doses of Sputnik V jabs annually

Live Mint  

Russia’s sovereign wealth fund on Tuesday said it signed a manufacturing pact with Serum Institute of India, through which the world’s largest vaccine maker will produce more than 300 million doses of the Sputnik V vaccine a year. With high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people …

Serum Institute to start production of Sputnik V vaccine in India from September
3 years, 5 months ago

Serum Institute to start production of Sputnik V vaccine in India from September

India Today  

The Russian Direct Investment Fund, Russia’s sovereign wealth fund, and Serum Institute of India have announced plans to start the production of the Sputnik V vaccine in India. The first batch of Sputnik V vaccine is expected to be produced at the Serum Institute’s facilities starting September. Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, “RDIF is delighted …

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India
3 years, 5 months ago

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India

Live Mint  

French pharmaceutical Sanofi and its British partner GlaxoSmithKline on Thursday said they have received the approval of the drugs controller general of India to conduct part of the global phase-3 efficacy trial of their jointly developed covid-19 vaccine in India. We believe our covid-19 adjuvanted, recombinant vaccine can make a significant contribution to the ongoing fight against covid-19 and are …

Sputnik V not yet available in many pvt hospitals in Delhi-NCR
3 years, 5 months ago

Sputnik V not yet available in many pvt hospitals in Delhi-NCR

India TV News  

Various private hospitals in Delhi-NCR are yet to start administering the Russian 'Sputnik V' Covid-19 vaccine. An Indraprastha Apollo hospital official told IANS on Sunday that Sputnik V was yet to be rolled out, but "the management is working on it". A Max Group Hospitals spokesperson said: "Sputnik V Covid vaccine is not available as of today." Fortis Healthcare, which …

Delhi NCR: Russian COVID-19 vaccine 'Sputnik V' roll-out delayed again
3 years, 5 months ago

Delhi NCR: Russian COVID-19 vaccine 'Sputnik V' roll-out delayed again

India TV News  

The roll-out of Russian COVID-19 vaccine 'Sputnik V' at various private hospitals in the Delhi-NCR region has been delayed again, officials said on Sunday. An official of Madhukar Rainbow Children's Hospital said the facility has also not received Sputnik V doses so far from Hyderabad-based Dr Reddy's Laboratories, the marketing partner for the vaccine in the country. Fortis Healthcare, which …

Pfizer's Covid-19 Vaccine to Get Nod in India Soon, CEO Says Deal 'In Final Stage'
3 years, 6 months ago

Pfizer's Covid-19 Vaccine to Get Nod in India Soon, CEO Says Deal 'In Final Stage'

News 18  

Pfizer CEO Albert Bourla on Tuesday said his US-based company is in the final stages of getting approval for its Covid-19 vaccine from the Indian government, adding that when approved, the pharma giant will supply one billion doses to India within this year. We have pledged to provide one billion doses of Covid-19 vaccine this year to nations under the …

Pfizer in final stages to get nod for covid vaccine in India: CEO Albert Bourla
3 years, 6 months ago

Pfizer in final stages to get nod for covid vaccine in India: CEO Albert Bourla

Live Mint  

Pharmaceutical company Pfizer is now in final stages to get approval for its Covid-19 vaccine in India, the company's CEO Albert Bourla said as reported by news agency ANI. Speaking at a virtual event, Pfizer Chief Executive Officer Albert Bourla said he hopes the company will finalize an agreement with the Indian government soon. I hope very soon we will …

Sputnik V vaccine protects from all known variants of Covid: Head of Russia's Gamaleya Institute
3 years, 6 months ago

Sputnik V vaccine protects from all known variants of Covid: Head of Russia's Gamaleya Institute

India Today  

Russian-made Sputnik V vaccine protects against all known variants of Covid-19, said Alexander Gintsburg. In a statement on Tuesday, Alexander Gintsburg said, "Antibodies developed after vaccination with #SputnikV protect from all variants of COVID known today, starting from the UK variant to the so-called Delta variant, first detected in India." "Antibodies developed after vaccination with #SputnikV protect from all variants …

Pfizer's Covid vaccine in final stages of getting approval in India: CEO Albert Bourla
3 years, 6 months ago

Pfizer's Covid vaccine in final stages of getting approval in India: CEO Albert Bourla

India Today  

Pfizer is now in the final stages of getting emergency use approval for its Covid-19 vaccine in India, said the company's Chairman and CEO, Albert Bourla. READ: Pfizer to test Covid-19 vaccine in larger group of children below 12 NITI Aayog member Dr VK Paul told CNBC-TV18 on Monday that the central government is in talks with Pfizer and other …

Roll out of Russia's Sputnik V COVID-19 vaccine delayed in Delhi hospitals
3 years, 6 months ago

Roll out of Russia's Sputnik V COVID-19 vaccine delayed in Delhi hospitals

Firstpost  

The administering of the vaccine at Indraprastha Apollo, Madhukar Rainbow Children’s Hospital, and Fortis hospital in Delhi has been delayed for some days, officials said New Delhi: The roll out of Russian COVID-19 vaccine Sputnik V at Indraprastha Apollo and Madhukar Rainbow Children’s Hospital in Delhi has been delayed for some days, officials said on Sunday. Follow LIVE updates on …

COVID-19 vaccine Sputnik V rollout delayed in Delhi
3 years, 6 months ago

COVID-19 vaccine Sputnik V rollout delayed in Delhi

Live Mint  

The roll out of Russian COVID-19 vaccine Sputnik V at Indraprastha Apollo and Madhukar Rainbow Children's Hospital in Delhi has been delayed for some days, officials said on Sunday. An official had earlier said the hospital would start giving Sputnik V jabs by June 20. Fortis Healthcare, which had said it would make Sputnik V available at its Gurgaon and …

COVID-19: Sputnik V roll out delayed in Delhi
3 years, 6 months ago

COVID-19: Sputnik V roll out delayed in Delhi

India TV News  

The roll out of Russian COVID-19 vaccine Sputnik V at Indraprastha Apollo and Madhukar Rainbow Children's Hospital in Delhi has been delayed for some days, officials said on Sunday. An official had earlier said the hospital would start giving Sputnik V jabs by June 20. Fortis Healthcare, which had said it would make Sputnik V available at its Gurgaon and …

Sputnik V likely to be available at Delhi hospital from today
3 years, 6 months ago

Sputnik V likely to be available at Delhi hospital from today

Hindustan Times  

Sputnik V, the Russian-made vaccine against Covid-19, is likely to be available at Indraprastha Apollo Hospital in Delhi from Tuesday, according to a report. Apart from Apollo Hospitals, Madhukar Rainbow Children’s Hospital in Delhi will also start administering the Sputnik V Covid-19 vaccine to people by the end of this week. ANI also reported, citing people familiar with the matter, …

The Science Behind Covid-19 Vaccines Approved by India - News18
3 years, 6 months ago

The Science Behind Covid-19 Vaccines Approved by India - News18

News 18  

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country’s drug regulator for emergency use approval of its Covid-19 vaccine, which showed a 66.6% efficacy against positive cases in an interim analysis. The development comes a day after Cipla on Tuesday received the approval from the Drugs Controller General of India to import Moderna’s coronavirus vaccine for …

Centre to Revise Vaccine Prices, In Talks with Serum Institute and Bharat Biotech
3 years, 6 months ago

Centre to Revise Vaccine Prices, In Talks with Serum Institute and Bharat Biotech

News 18  

The Centre is reportedly in talks with Serum Institute and Bharat Biotech over a revision of Covid-19 vaccine prices, days after issuing fresh procurement guidelines. “The revised procurement price per dose is yet to be decided under the new system”, a senior government official told the Indian Express. On Tuesday announced revised prices of Covid-19 vaccines for private hospitals, fixing …

Russia only country in world ready to transfer anti-COVID vaccine technology, says Vladimir Putin
3 years, 6 months ago

Russia only country in world ready to transfer anti-COVID vaccine technology, says Vladimir Putin

Firstpost  

The Russian president made the remarks during a virtual interaction with senior editors of international news agencies and rejected concerns over Sputnik V’s efficacy St. Petersburg: As Indian companies get ready to manufacture Russian-made Sputnik V anti-COVID vaccine to meet the staggering demand in the country, Russian president Vladimir Putin on Saturday said Russia is the only country in the …

India's daily Covid-19 cases fall to 120,529, active cases dip to over 1.5 million
3 years, 6 months ago

India's daily Covid-19 cases fall to 120,529, active cases dip to over 1.5 million

Hindustan Times  

India’s daily caseload of the coronavirus disease witnessed a further dip, as 120,529 cases were recorded in the last 24 hours, the Union ministry of health and family welfare data, updated at 8am on Saturday, showed. India’s latest positive cases were out of 2,084,421 samples tested for the viral disease, the government-run Indian Council of Medical Research tweeted on Saturday …

Serum Institute of India gets DCGI's nod to manufacture Sputnik V in India for test, analysis
3 years, 6 months ago

Serum Institute of India gets DCGI's nod to manufacture Sputnik V in India for test, analysis

Firstpost  

The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology in Moscow for developing Sputnik V at its licensed Hadapsar facility New Delhi: The DCGI has granted permission to the Serum Institute of India to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday. The Pune-based …

SII gets DCGI’s nod to manufacture Sputnik
3 years, 6 months ago

SII gets DCGI’s nod to manufacture Sputnik

Hindustan Times  

The Drugs Controller General of India on Friday granted permission to Serum Institute of India to manufacture Sputnik V, which will allow the production of doses for testing. Sputnik V is currently being distributed in India by Dr Reddy’s Laboratories, which signed a pact with the Russian Direct Investment Fund, which globally markets the Covid-19 vaccine developed by Russia’s Gamaleya …

Coronavirus Live News Updates: No home quarantine in Assam for COVID-19 patients with comorbidities, says Himanta Biswa Sarma
3 years, 6 months ago

Coronavirus Live News Updates: No home quarantine in Assam for COVID-19 patients with comorbidities, says Himanta Biswa Sarma

Firstpost  

9:13 PM Whatsapp Facebook Twitter Coronavirus Live News Updates No decision on indemnity to foreign or Indian vaccine makers yet: Centre No decision on granting indemnity to any foreign or Indian Covid vaccine-manufactures has been taken yet, the government said Friday, underlining these decisions are to be taken “in the interest of nation and people”. NITI Aayog member Dr VK …

Discover Related